Published in Clin Epigenetics on November 16, 2016
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
Epigenetics in cancer. N Engl J Med (2008) 17.36
Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet (2010) 15.70
Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature (2010) 9.81
Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med (1997) 8.59
Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A (2008) 8.39
Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80
Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A (2008) 4.71
Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet (2012) 4.04
DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet (2012) 3.33
Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res (2010) 3.17
Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res (2011) 2.51
Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity (2011) 2.49
Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet (2003) 2.39
Evolutionarily conserved sequence elements that positively regulate IFN-gamma expression in T cells. Proc Natl Acad Sci U S A (2004) 2.21
Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol (2002) 2.19
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97
Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One (2012) 1.91
OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant (2013) 1.84
Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol (2002) 1.81
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Timing is everything: the when and how of environmentally induced changes in the epigenome of animals. Epigenetics (2011) 1.67
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol (2013) 1.52
Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J Immunol (2003) 1.49
Role of the PD-1 pathway in the immune response. Am J Transplant (2012) 1.35
Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation (2004) 1.25
Which T cells mediate allograft rejection? Transplantation (1985) 1.21
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19
DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology. J Epidemiol (2012) 1.19
Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urol Oncol (2013) 1.17
Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells. J Immunol (2013) 1.14
CpG methylation patterns in the IFNgamma promoter in naive T cells: variations during Th1 and Th2 differentiation and between atopics and non-atopics. Pediatr Allergy Immunol (2006) 1.12
Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med (2011) 1.03
Role of DNA methylation in the nucleus accumbens in incubation of cocaine craving. J Neurosci (2015) 1.02
DNA methylation: a promising landscape for immune system-related diseases. Trends Genet (2012) 0.97
Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection. Transplantation (2012) 0.96
Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ. Front Immunol (2013) 0.94
DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics (2013) 0.92
Loss of methylation at the IFNG promoter and CNS-1 is associated with the development of functional IFN-γ memory in human CD4(+) T lymphocytes. Eur J Immunol (2013) 0.92
Epigenetic modulation of the immune function: a potential target for tolerance. Epigenetics (2013) 0.90
SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes. Circ Cardiovasc Genet (2012) 0.90
Epigenetic modulation of host: new insights into immune evasion by viruses. J Biosci (2010) 0.90
Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with IgE-mediated cow's milk allergy. Clin Epigenetics (2015) 0.89
DNA methylation of the allergy regulatory gene interferon gamma varies by age, sex, and tissue type in asthmatics. Clin Epigenetics (2014) 0.86
Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations. Epigenetics (2014) 0.84
The interface between transcriptional and epigenetic control of effector and memory CD8⁺ T-cell differentiation. Immunol Rev (2014) 0.82
Increased numbers of circulating CD8 effector memory T cells before transplantation enhance the risk of acute rejection in lung transplant recipients. PLoS One (2013) 0.82
DNA methylation perspectives in the pathogenesis of autoimmune diseases. Clin Immunol (2016) 0.81
Epigenetic alterations underlying autoimmune diseases. Autoimmunity (2016) 0.79
Epigenetics: time to translate into transplantation. Transplantation (2012) 0.78
Targeting CD8 T-Cell Metabolism in Transplantation. Front Immunol (2015) 0.77
Renal allograft rejection--in situ demonstration of cytotoxic intratubular cells. Transplantation (1996) 0.77
T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection. Ther Drug Monit (2016) 0.76
Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions. Transplantation (2016) 0.76
The Emerging Role of DNA Methylation in Kidney Transplantation: A Perspective. Am J Transplant (2016) 0.76
New opportunities for organ transplantation research: epigenetics is likely to be an important determinant of the host immune response. Epigenomics (2013) 0.76
Clinical potential of DNA methylation in organ transplantation. J Heart Lung Transplant (2016) 0.75
Measuring Quality Improvement in Acute Ischemic Stroke Care: Interrupted Time Series Analysis of Door-to-Needle Time. Cerebrovasc Dis Extra (2014) 0.83